MedTrace Logo

PMS Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention

NCT02373852 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2019-09-12

Study results available
· View outcomes & findings →

Summary

The objective of this study is to collect data on the use of the WIRION system in Patients undergoing Percutaneous Intervention of Saphenous Vein Graft (SVG).

Conditions

  • Stenosis

Interventions

DEVICE

Saphenous vein graft (SVG) stenting

Opening and stenting of blocked SVG with the use of the WIRION embolic protection filter

Sponsors & Collaborators

  • Gardia Medical

    lead INDUSTRY

Principal Investigators

  • Vardit Segal, PhD · Gardia medical manufacture the WIRION used in the study

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-05-31
Completion
2016-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02373852 on ClinicalTrials.gov